S
Sigilon Therapeutics
2 followers
Sigilon Therapeutics’ mission is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases.
Org chart
Rogerio Vivaldi
President & CEO
Collapse
Sarah Yuan
Chief Technical Operations Officer
Philip Ashton-Rickardt
Chief Scientific Officer
Olivia G. Kelly
VP, Head, Islet Cell Therapy Research
Joseph Tumang
VP & Head, Immune Mediated Diseases
Jamie Murphy
VP, Finance & Controller
Omid Veiseh
Co-founder
Eric Shaff
Corporate Director
Board & advisors
José Oberholzer
Founder
Arturo Vegas
Founder
Omid Veiseh
Founder
Daniel G. Anderson
Founder & Scientific Advisor
Constance Cepko
Advisor
Robert Langer
Advisor
Ulrik B. Nielsen
Advisor
Michael Rosenblatt
Advisor
Teams
Offices
Similar companies
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
2 followers
Gilead Sciences
148 followers
Regeneron
111 followers
Illumina
76 followers
Agilent Technologies
77 followers
Verily Life Sciences
42 followers
Alexion Pharmaceuticals
40 followers
Explore companies